Endometriosis pathophysoiology, diagnosis, and treatment

Nurse Practitioner

Volumn 22, Issue 10, 1997, Pages 35-44

  Corwin, Elizabeth J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ENDOMETRIOSIS; FEMALE; HUMAN; IMMUNOLOGY; INFERTILITY; MENSTRUATION DISORDER; MIDDLE AGED; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; REVIEW;

ENDOMETRIOSIS; ADOLESCENT; ADULT; FEMALE; HUMANS; INFERTILITY; MENSTRUATION DISTURBANCES; MIDDLE AGED; PATIENT EDUCATION;

EID: 0031255240     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-199710000-00006     Document Type: Article

References (62)

1. Klotz MM: Dysmenorrhea, endometriosis, and pelvic pain. In: Lemcke DP, Pattison J, Marshall L, Cowley DS, Eds. Primary Care of Women. Norwalk: Appleton & Lange, 1995:26.
2. Pepping PB: Endometriosis—A nursing perspective. Innovations in Women’s Health Nursing 1994;1:2-8.
3. Gleicher WP: Immune dysfunction—a potential target for treatment in endometriosis. Br J Obstet Gynaecol 1995;102(Supp 12):4-7.
4. Sangi-I-Iaghpcykar H, Poindexter AN: Epidemiology of endometriosis among parous women. Obstet Gynecol 1995;85:983-92.
5. Goldmann BB, Cramer DW; The epidemiology of endometriosis. In: Brosens I, Donnet J, eds. Current Concepts in Endometriosis. New York: Alan R. Liss Inc, 1990:15-31.
6. Olive DL: Endometriosis: advances in understanding and management. Current Opinion in Obstet Gynecol 1992;4:380-87.
7. Velebil P, Wingo PA, Zhisen X, et al: Rate of hospitalization for gynecologic disorders among reproductive age women in the United States. Obstet Gynecol 1995;86:764-69.
8. Gruppo italiano per lo studio dell’endometriosis: Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions: results from a multicentric Italian study. Hum Reprod 1994;9:1158-62.
9. Vessey MP, Villard-Mackintosh L, Painter R: Epidemiology of endometriosis in women attending family planning clinics. BMJ 1993;306:182-84.
10. Sanfilippo JS: Endometriosis in adolescents. In: Wilson EA, ed. Endometriosis. New York: Liss Inc, 1987: 161-72.
11. Muse KN, Fox MD: Endometriosis. In: DeCherney AH, Pernoll ML, eds. Current Obstetric and Gynecologic Diagnosis and Treatment, 8th ed. Norwalk: Appleton & Lange, 1994:801-07.
12. Brough RJ, O’Flynn K: Recurrent pelvic endometriosis and bilateral ureteric obstruction associated with hormone replacement therapy. BMJ 1996; 312:1221-22.
13. Kirshon B, Poindexter AN: Contraception: a risk factor for endometriosis. Obstet Gynecol 1988;71: 829-31.
14. Mahmood TA, Templeton A: Prevalence and genesis of endometriosis. Hum Reprod 1991;6:544-49.
15. Moen MH: Endometriosis in women at interval sterilization. Acta Obstet Gynecol Scand 1987;66:451-54.
16. Cramer DW, Wilson E, Stillman RJ, et al: The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA 1986;255:1904-08.
17. Strathy JH, MoJgaard CA, Coulam CB, et al: Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 1982;38:667-72.
18. O’Conner DT: Endometriosis. London: Churchill Livingstone, 1986:13.
19. Moen MH, Magnus P: The familial risk of endometriosis. Acta Obstet Gynecol Scand 1993;72:560-64.
20. Simpson JL, Elias S, Malinak LR, et al: Heritable aspects of endometriosis. I. Genetic studies. AmJ Obstet Gynecol 1980;137:327-31.
21. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. AmJ Obstet Gynecol 1927; 14:422-69.
22. Halme J, Hammond MG, Hulka JF, et al: Retrograde menstruation in healthy women and in patients widi endometriosis. Obstet Gynecol 1984;64: 151-54.
23. Dmowski WP: Immunological aspects of endometriosis. Int J Gynaecol Obstet 1995;50(supp 1): S3-10.
24. Dmowski WP, Gebel HM, Braun DP: The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand 1994; 159 (Supp):7-14.
25. Oosterlynck DJ, Meuleman C, Waer M, et al: The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992;58:290-95.
26. Oosterlynck DJ, Cornilie FJ, Vandeputte M, et al: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51.
27. Oosterlynck DJ, Meuleman C, Lacquct FA, et al: Flow cytometry analysis of lymphocyte subpopulations in peritoneal fluid of women with endometriosis. AmJ Reprod Immunol 1994;31:25-31.
28. Oosterlynck DJ, Meuleman C, Waer M, et al: Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993;82:206-12.
29. Iwasaki K, Makino T, Maruyama T, et al: Leukocyte subpopulations and natural killer activity in endometriosis. Int J Fertil 1993;38:229-34.
30. Wang HS, Kanazaki H, Yoshida M, et al: Suppression of lymphocyte reactivity in vitro by supernatants of explants of human endometrium. Am J Obstet Gynecol 1987;157:956-63.
31. Akoum A, Lemay A, Bronet C, et al: Cytokine-induced secretion of monocyte chemotactic protein-1 by human endomctriotic cells in culture. Am J Obstet Gyncol 1995;172:594-600.
32. Oosterlynck DJ, Meuleman C, Waer M, et al: (1994). Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994; 83:287-92.
33. Rana N, Braun DP, House R, et al: Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril 1996;65:925-30.
34. Wahl SM, Hunt DA, Wakefield: Transforming growth factor type Beta induces monocyte chemotaxis and growth factor production. Proceedings of the National Academy of Science USA 1987;84:5788-92.
35. Oosterlynck DJ, Meuleman C, Sobis H, et al: Angiogenic activity of peritoneal fluid from women widi endometriosis. Fertil Steril 1993;59:778-82.
36. Gaetjii R, Lotzian S, Herrmann G, et al: Invasiveness of endometriotic cells in vitro. Lancet 1995;346:1463-64.
37. Dmowski WP, Braun D, Gebel H: The immune system in endometriosis. In: Rock J, ed. Modern Approaches to Endometriosis. New York: Kluwer Academic Publishers, 1991:97.
38. Gleicher N, El-Roeiy A, Confino E, et al: Is endometriosis an autoimmune disease? Obstet Gynecol 1987;170:115-22.
39. Mathur S, Peress MR, Williamson HO: Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immun 1982;50:259-65.
40. Dmowski WP, Rana N, Michalowska J, et al: The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995;63: 555-62.
41. Grimes DA, Lebolt SC, Grimes KR: Systemic lupus erythematosus and reproductive function: a case control study. AmJ Obstet Gynecol 1985;153:179-85.
42. Dhabhar FS, Miller AH, McEwen BS, et al: Effects of stress on immune cell distribution. J Immun 1995;154:5511-27.
43. Rier SE, Matin DC, Bowman RE, et al: Endometriosis in rhesus monkeys following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fund Appl Toxicol 1993;21:433-41.
44. Mitchell-Leef DE: Endometriosis. In: Hurst JW, ed. Medicine for die Practicing Physician, 4th ed. Stamford: Appleton & Lange, 1996:751-55.
45. Damario MA, Rock KJA: Goserclin (Zoladex) versus danazol for endometriosis: die North American experience. Br J Obstet Gynaecol 1994;101:13-18.
46. Keltz MD, Kliman HJ, Arici AM, et al: Endosnlpingiosis found at laparoscopy for chronic pelvic pain. Fertil Steril 1995;64:482-85.
47. Halstead LK, Pepping P, Haile L, et al: Women’s experiences with endometriosis: Delay and disbelief. Brussels, Belgium: Third World Congress on Endometriosis, 1992.
48. American Fertility Society: Management of endometriosis in the presence of pelvic pain. Fertil Steril 1993;60:952-55.
49. Martin DC: Pain and infertility—a rationale for different treatment approaches. BrJ Ohstet Gynaecol 1995;102(supp 12):2-3.
50. Marcoux S, Maheux R, Beruhe S, et al: Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med 1997;337:217-22.
51. Rcdwine DB: Conservative laparoscopic excision of endometriosis by sharp dissection: Life table analysis of reoperation and persistent or recurrent disease. Fertil Steril 1991;56:629-34.
52. Wheeler JM, Malinak LR: Recurrent endometriosis: incidence, management and progression. Am J Obstet Gynecol 1983;146:247-50.
53. Rcdwine DB: Endometriosis persisting after castration: clinical characteristics and results of surgical management. Obstet Gynecol 1994;83:405-13.
54. Stcinlcitner A, Lambert H, Suarez M, et al: Periovulatoiy calcium channel blockade enhances rerpoductive performance in an animal model for endometriosis-associated subfertility. Am J Ohstet Gynecol 1991;164:949-52.
55. Sagraves R, Letassy NA: Gynecological disorders. In: Young LY, Koda-Kimble MA, eds. Applied Therapeutics: The Clinical Use of Drugs, 6th ed. Vancouver: Applied Therapeutics, 1995:46,18-46.
56. Newhall-Peny K, Holloway L, Osburn L, et al: Effects of a gonadotropin-re-leasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis. Atn J Obstet Gynecol 1995; 173:824-29.
57. Stevenson JC: The impact of bone loss in women with endometriosis. Int J Gynaecol Obslet 1995; 50(Supp 1):S11-S15.
58. Mukhcrjee T, Bared D, Turk R, et al: A randomized placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment. Am J Ohstet Gynecol 1996;175:105-09.
59. Waller KG, Shaw RW: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 1993;59:511-15.
60. Barbieri RL, Evans S, Kristner RW: Danazol in the treatment of endometriosis: analysis of 100 cases with a four year follow-up. Fertil Steril 1982; 37:737-46.
61. Halstead LK: Living with a chronic disease: th psychological impact of endometriosis. Innovations in Women’s Health Nursing 1994;1:13-16.
62. Damario MA, Rock JA: Pain recurrence: a quality of life issue in endometriosis. Int J Gynaecol Obstet 1994;50(Supp l):S27-42.